Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
MiR-126: a novel route for natalizumab action?
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
CCSVI and MS: no meaning, no fact.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Characterization of human platelet binding of recombinant T cell receptor ligand.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
The benefits of exercise training in multiple sclerosis.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Over six cups of coffee a day may reduce the risk of developing multiple sclerosis.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

Pages